# Comparison of Sevikar® and the Combination of Perindopril/Amlodipine on Central Blood Pressure

Study · id `cardio:ct-nct01101009` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01101009](<https://clinicaltrials.gov/study/NCT01101009>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01101009

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 486 participants.

## Technical summary

Registry record NCT01101009. Randomized; double masking; primary purpose treatment. Start 2010-04 (registry gives no type); primary completion 2012-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 486 participants (enrolled count; ClinicalTrials.gov record NCT01101009, source copy `cardio:ctgov-nct01101009-2018-12-24`, retrieved 2026-10-26)
- Start date: 2010-04 (registry gives no type) (ClinicalTrials.gov record NCT01101009, source copy `cardio:ctgov-nct01101009-2018-12-24`, retrieved 2026-10-26)
- Primary completion: 2012-11 (actual) (ClinicalTrials.gov record NCT01101009, source copy `cardio:ctgov-nct01101009-2018-12-24`, retrieved 2026-10-26)
- Completion: 2012-12 (actual) (ClinicalTrials.gov record NCT01101009, source copy `cardio:ctgov-nct01101009-2018-12-24`, retrieved 2026-10-26)
- Countries: Spain (ClinicalTrials.gov record NCT01101009, source copy `cardio:ctgov-nct01101009-2018-12-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01101009-2018-12-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of Sevikar® and the Combination of Perindopril/Amlodipine on Central Blood Pressure
- Condition: Hypertension
- Intervention (Drug): Perindopril + amlodipine + if necessary, hydrochlorothiazide
- Intervention (Drug): olmesartan/amlodipine + hydrochlorothiazide, if necessary.
- Lead sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company (`cardio:org-daiichi-sankyo-europe-gmbh-a-daiichi-sankyo-company`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: The fixed-dose combination of olmesartan/amlodipine was superior in central aortic blood pressure reduction compared with perindopril/amlodipine: a randomized, double-blind trial in patients with hypertension (`cardio:pubmed-24293132`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 9f9e987d61591e8f5184e0f77ef9f03a9be7b998219c7584fb0db4bb2f2d5143
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
